In our study, given consistent upregulation of IL-6, IL-15, and IL-18 in JDM patient serum and media of IFN-stimulated myobundles, future study of these specific myokines as potential biomarkers and mechanistic drivers of JDM is warranted. The gene discussed is IL18; the disease is juvenile dermatomyositis.